Roche Pharma has launched Tecentriq, India’s first under-the-skin immunotherapy for non small cell lung cancer. The injection takes about seven minutes, aiming to cut the burden of longer intravenous sessions. By simplifying administration, the company says the treatment can improve patient experience and quality of life while delivering essential cancer care more conveniently.
A major private hospital group has warned that a reimbursement cap under the Central Government Health Scheme is straining finances for hospitals treating advanced cancer. The cap on life-saving immunotherapy drugs is pushing essential medicines beyond affordability for many CGHS beneficiaries, according to the association, which says nine specific drugs are now out of reach and may limit access to treatment.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
India’s cancer care is shifting as cheaper immunotherapy drugs developed in China arrive through Indian partnerships. Oncologists say these options are expanding access for patients who cannot afford pricier Western medicines. The result, doctors claim, is less financial strain and fewer cases where cancer treatment drives families into severe debt, alongside improving affordability of sustained care.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
